Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001829126-25-002829
Filing Date
2025-04-22
Accepted
2025-04-22 16:30:57
Documents
3
Period of Report
2025-04-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A titanpharma_pre14a.htm PRE 14A 364402
2 GRAPHIC img_001.jpg GRAPHIC 45505
3 GRAPHIC img_002.jpg GRAPHIC 45726
  Complete submission text file 0001829126-25-002829.txt   491361
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-13341 | Film No.: 25858115
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)